MetLife, Inc. (NYSE: MET) today reported third quarter 2011 net income
of $3.6 billion, or $3.33 per share, and operating earnings1
of $1.2 billion, or $1.11 per share.
"During the third quarter, MetLife generated strong results, despite
continued challenging economic conditions,” said Steven A. Kandarian,
president and chief executive officer of MetLife, Inc. "We increased
operating earnings 23%, generated a record $12.0 billion in premiums,
fees and other revenues and had strong top line growth in both our U.S.
and International Businesses compared with the third quarter of 2010. We
also demonstrated that, despite several unusual items during the third
quarter, the core fundamentals of our diverse, global businesses are
strong, and we remain committed to delivering further value for our
customers and our shareholders.”
1 Information regarding the non-GAAP financial measures
included in this press release and the reconciliation of them to GAAP
measures are provided in the Non-GAAP and Other Financial Disclosures
discussion below, as well as in the tables that accompany this release
and/or the Third Quarter 2011 Quarterly Financial Supplement.
THIRD QUARTER 2011 SUMMARY
-
Operating earnings of $1.2 billion, or $1.11 per share, reflecting:
-
a $117 million ($0.11 per share), after tax, charge to increase
reserves in connection with the company’s use of the U.S. Social
Security Administration’s Death Master File and similar databases
to identify potential life insurance claims that have not yet been
presented to the company; the charge mostly impacted the Insurance
Products segment
-
severe storm-related catastrophe losses in the Auto & Home
business that were $50 million ($0.05 per share), after tax,
higher than the company’s quarterly plan provision of $38 million
-
strong variable investment income, which was above the plan range
by $37 million, or $0.03 per share, after tax and the impact of
deferred acquisition costs ("DAC”)
-
a net charge of $40 million ($0.04 per share), after tax, related
to the liquidation plan for Executive Life Insurance Company of
New York ("ELNY”) filed by the New York State Department of
Financial Services; the charge was recorded in Corporate & Other
-
U.S. annuity sales of $9.2 billion, up 79% over the third quarter of
2010, driven by strong demand for variable annuities
-
Total International sales more than doubled on a reported basis over
the third quarter of 2010 and were up 25% compared with combined
MetLife and Alico third quarter 2010 results
-
Premiums, fees & other revenues of $12.0 billion, up 41% over the
third quarter of 2010, largely due to the acquisition of Alico as well
as growth in U.S. Business
|
|
|
($ in millions, except per share data)
|
|
|
|
|
For the three months ended September 30,
|
|
|
|
|
|
|
2011
|
|
|
2010
|
|
|
Change
|
|
Premiums, fees & other revenues
|
|
|
|
|
$
|
11,965
|
|
|
$
|
8,506
|
|
|
41
|
%
|
|
Total operating revenues
|
|
|
|
|
$
|
17,017
|
|
|
$
|
12,820
|
|
|
33
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
|
|
$
|
3,552
|
|
|
$
|
286
|
|
|
–
|
|
|
Net income per share
|
|
|
|
|
$
|
3.33
|
|
|
$
|
0.32
|
|
|
–
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating earnings
|
|
|
|
|
$
|
1,179
|
|
|
$
|
958
|
|
|
23
|
%
|
|
Operating earnings per share
|
|
|
|
|
$
|
1.11
|
|
|
$
|
1.08
|
|
|
3
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Book value per share
|
|
|
|
|
$
|
55.13
|
|
|
$
|
48.93
|
|
|
13
|
%
|
|
Book value per share excluding AOCI
|
|
|
|
|
$
|
48.69
|
|
|
$
|
44.48
|
|
|
9
|
%
|
BUSINESS SEGMENT DISCUSSIONS
All comparisons of third quarter 2011 results in the segment discussions
that follow are with the third quarter of 2010, unless otherwise noted.
Reconciliations of segment net income to segment operating earnings are
provided in the tables that accompany this release and in the Third
Quarter 2011 Quarterly Financial Supplement, which is available on the
Investor Relations section of www.metlife.com.
U.S. BUSINESS
-
U.S. Business operating earnings of $655 million, down 23% primarily
due to the previously mentioned reserve increase and higher
catastrophe losses
-
Variable annuity sales of $8.6 billion, up 84%
-
Continued improvement in non-medical health underwriting results,
particularly in the dental business
-
Premiums, fees & other revenues of $7.7 billion, up 9% primarily due
to growth in Corporate Benefit Funding and Retirement Products
Insurance Products
Operating earnings for Insurance Products – which includes group life,
individual life and non-medical health insurance – were $265 million,
down 23% largely due to the previously mentioned reserve adjustment,
which impacted group and individual life results. Partially offsetting
this was a 31% increase in non-medical health earnings, which benefitted
from improved investment income and underwriting results. Premiums, fees
& other revenues for Insurance Products were $4.9 billion, relatively
unchanged.
Retirement Products
Operating earnings for Retirement Products – which includes the
company’s U.S. annuity products – were $104 million, down 56%. The
decrease was largely due to the initial negative impact of declining
equity markets, which reduced earnings by $90 million, after tax, as
well as lower net investment income. Total annuity sales increased 79%
to $9.2 billion due to strong growth in variable annuities across all
distribution channels. In addition, total annuity net flows were $5.8
billion, higher than the second quarter of 2011 and the third quarter of
2010. Premiums, fees & other revenues for Retirement Products were $1.1
billion, up 39% due to increased sales of immediate annuities and higher
fee income.
Corporate Benefit Funding
Operating earnings for Corporate Benefit Funding – which includes the
U.S. and U.K. pension closeout businesses, structured settlements and
other benefit funding products – were $264 million, up 45% primarily due
to higher net investment income. Premiums, fees & other revenues for
Corporate Benefit Funding were $854 million, up 65% due to higher
pension closeout sales (which often fluctuate significantly from quarter
to quarter) and higher structured settlement sales.
Auto & Home
Operating earnings for Auto & Home were $22 million, down 73% as storm
activity, including Hurricane Irene, contributed to catastrophe losses
of $88 million, after tax. Partially offsetting this was favorable
non-catastrophe claim development related to prior accident years of $19
million ($0.02 per share), after tax, compared with $3 million, after
tax, in the third quarter of 2010. Excluding catastrophes, Auto & Home’s
combined ratio was strong at 88.0%, compared with 88.2%. Net written
premiums for Auto & Home were $807 million, up 3%.
INTERNATIONAL BUSINESS
-
International operating earnings of $578 million, up from $189 million
largely due to the acquisition of Alico* and reflecting particularly
strong performance in the Latin America and Asia Pacific regions
-
Total International sales up 25% compared with combined MetLife and
Alico third quarter 2010 results
-
Premiums, fees & other revenues of $4.0 billion, reflecting growth
across all the regions as well as the positive impact of foreign
currency exchange rates
Japan
Operating earnings in Japan were $315 million, up 29% over the second
quarter of 2011 due to higher net investment income, reduced claims
associated with the March earthquake, lower operating expenses and
improved persistency. Sales grew 22% over the second quarter of 2011 and
28% over the third quarter of 2010. Premiums, fees & other revenues in
Japan were $1.8 billion.
Other International Regions
Operating earnings in the Other International Regions were $263 million,
up 39%, while premiums, fees & other revenues grew to $2.2 billion. The
increases were largely due to the Alico acquisition. In addition, in
Latin America, growth in premiums, fees & other revenues was driven by
higher immediate annuity sales in Chile, as well as premium increases in
Mexico and Argentina. In Asia Pacific, increases in institutional
business in Australia and in accident & health insurance in Korea drove
the growth in premiums, fees & other revenues.
*MetLife acquired Alico on November 1, 2010. Accordingly, Alico’s
financial results prior to that date are not reflected in MetLife’s
historical financial statements.
BANKING, CORPORATE & OTHER
Operating earnings for MetLife Bank were $51 million, down from $101
million, reflecting higher expenses. Operating revenues rose 4% to $425
million. At September 30, 2011, total assets were $17.7 billion
(including deposits of $10.7 billion), up 6% from September 30, 2010. On
October 12, MetLife announced that, in addition to its previously
announced decision to explore a sale of MetLife Bank’s depository
business, the company is also exploring a sale of the Bank’s forward
mortgage origination business.
Corporate & Other had an operating loss of $105 million, compared with
an operating loss of $178 million. Results in the third quarter of 2011
benefited from higher net investment income, partially offset by the
previously mentioned charge related to ELNY.
INVESTMENTS
-
Investment portfolio of $493.2 billion, up from $383.2 billion at
September 30, 2010 largely due to the acquisition of Alico
-
Strong net investment income of $5.1 billion
-
Investment portfolio net gain of $14 million, after tax (including
impairments of $167 million, after tax), compared with an investment
portfolio net loss of $72 million, after tax
Net investment income was $5.1 billion, up 17% from the third quarter of
2010 and relatively unchanged from the second quarter of 2011. During
the third quarter of 2011, variable investment income was $400 million
($258 million, after tax and the impact of DAC), driven by strong
performance from private equity funds and securities lending.
For the quarter, MetLife reported a $14 million, after tax, investment
portfolio net gain. Separately, the impact of MetLife’s credit spreads
contributed $1.3 billion, after tax, to total derivative net gains of
$2.7 billion, after tax. Lower interest rates also contributed to the
total derivative net gains for the quarter. In the third quarter of
2010, MetLife reported $190 million, after tax, in derivative net
losses. MetLife uses derivatives in connection with its broader
portfolio management strategy to hedge a number of risks, including
changes in interest rates and fluctuations in foreign currencies.
Movement in interest rates, foreign currencies and MetLife’s credit
spreads – which impact the valuation of certain insurance liabilities –
can generate derivative gains or losses. Derivative gains or losses
related to MetLife’s credit spreads do not have an economic impact on
the company.
Conference Call
MetLife will hold its third quarter 2011 earnings conference call on
Friday, October 28, 2011, at 8:00 a.m. (ET). Following the discussion of
the company’s third quarter 2011 results, MetLife will host a separate
discussion at 9:05 a.m. (ET) to address market concerns about a
potential long-term low interest rate environment in the U.S.
Presentation materials for the interest rate discussion will be
available at www.metlife.com
(through a link on the Investor Relations page).
The entire conference call will be available live via telephone. To
listen, dial (612) 326-1011 (domestic and international callers). Please
note that there will be no audio Webcast of the earnings discussion or
the interest rate discussion, and participants must dial the
above-mentioned number to listen to the call. To view the interest rate
presentation materials, visit https://metlife.webex.com/metlife/onstage/g.php?d=639282138&t=a.
The event password for the presentation is mlirq3.
The entire conference call will be available for replay via telephone
beginning at 12:00 p.m. (ET) on Friday, October 28, 2011, until Friday,
November 4, 2011 at 11:59 p.m. (ET). To listen to a replay of the
earnings conference call, dial (320) 365-3844 (domestic and
international callers), access code 169216. To listen to a replay of the
interest rate-related conference call, dial (320) 365-3844 (domestic and
international callers), access code 222037.
Non-GAAP and Other Financial Disclosures
All references in this press release (except in this section) to net
income (loss), net income (loss) per share, operating earnings,
operating earnings per share and book value per share should be read as
net income (loss) available to MetLife, Inc.’s common shareholders, net
income (loss) available to MetLife, Inc.’s common shareholders per
diluted common share, operating earnings available to common
shareholders, operating earnings available to common shareholders per
diluted common share and book value per common share, respectively.
Operating earnings is the measure of segment profit or loss that MetLife
uses to evaluate segment performance and allocate resources and,
consistent with accounting principles generally accepted in the United
States of America ("GAAP”) accounting guidance for segment reporting, it
is MetLife’s measure of segment performance. Operating earnings is also
a measure by which MetLife senior management’s and many other employees’
performance is evaluated for the purposes of determining their
compensation under applicable compensation plans.
Operating earnings is defined as operating revenues less operating
expenses, both net of income tax. Operating earnings available to common
shareholders is defined as operating earnings less preferred stock
dividends.
Operating revenues exclude net investment gains (losses) ("NIGL”) and
net derivative gains (losses) ("NDGL”). The following additional
adjustments are made to GAAP revenues, in the line items indicated, in
calculating operating revenues:
-
Universal life and investment-type product policy fees exclude the
amortization of unearned revenue related to NIGL and NDGL and certain
variable annuity guaranteed minimum income benefits ("GMIB”) fees
("GMIB Fees”);
-
Net investment income: (i) includes amounts for scheduled periodic
settlement payments and amortization of premium on derivatives that
are hedges of investments but do not qualify for hedge accounting
treatment, (ii) includes income from discontinued real estate
operations, (iii) excludes post-tax operating earnings adjustments
relating to insurance joint ventures accounted for under the equity
method, (iv) excludes certain amounts related to
contractholder-directed unit-linked investments, and (v) excludes
certain amounts related to securitization entities that are variable
interest entities ("VIEs”) consolidated under GAAP; and
-
Other revenues are adjusted for settlements of foreign currency
earnings hedges.
The following adjustments are made to GAAP expenses, in the line items
indicated, in calculating operating expenses:
-
Policyholder benefits and claims and policyholder dividends exclude:
(i) changes in the policyholder dividend obligation related to NIGL
and NDGL, (ii) inflation-indexed benefit adjustments associated with
contracts backed by inflation-indexed investments and amounts
associated with periodic crediting rate adjustments based on the total
return of a contractually referenced pool of assets, (iii) benefits
and hedging costs related to GMIBs ("GMIB Costs”), and (iv) market
value adjustments associated with surrenders or terminations of
contracts ("Market Value Adjustments”);
-
Interest credited to policyholder account balances includes
adjustments for scheduled periodic settlement payments and
amortization of premium on derivatives that are hedges of policyholder
account balances but do not qualify for hedge accounting treatment and
excludes amounts related to net investment income earned on
contractholder-directed unit-linked investments;
-
Amortization of DAC and value of business acquired ("VOBA”) excludes
amounts related to: (i) NIGL and NDGL, (ii) GMIB Fees and GMIB Costs
and (iii) Market Value Adjustments;
-
Amortization of negative VOBA excludes amounts related to Market Value
Adjustments;
-
Interest expense on debt excludes certain amounts related to
securitization entities that are VIEs consolidated under GAAP; and
-
Other expenses exclude costs related to: (i) noncontrolling interests,
(ii) implementation of new insurance regulatory requirements, and
(iii) business combinations.
MetLife believes the presentation of operating earnings and operating
earnings available to common shareholders as MetLife measures it for
management purposes enhances the understanding of the company’s
performance by highlighting the results from operations and the
underlying profitability drivers of the business. Operating revenues,
operating expenses, operating earnings, operating earnings available to
common shareholders, operating earnings available to common shareholders
per diluted common share, book value per common share, excluding
accumulated other comprehensive income (loss) ("AOCI”) and book value
per diluted common share, excluding AOCI should not be viewed as
substitutes for the following financial measures calculated in
accordance with GAAP: GAAP revenues, GAAP expenses, GAAP income (loss)
from continuing operations, net of income tax, GAAP net income (loss)
available to MetLife, Inc.’s common shareholders, GAAP net income (loss)
available to MetLife, Inc.’s common shareholders per diluted common
share, book value per common share and book value per diluted common
share, respectively. Reconciliations of these measures to the most
directly comparable GAAP measures are included in the Third Quarter 2011
Quarterly Financial Supplement and in the tables that accompany this
earnings press release.
Statistical sales information for life insurance is calculated by
MetLife using the LIMRA International, Inc. definition of sales for core
direct sales, excluding company sponsored internal exchanges,
corporate-owned life insurance, bank-owned life insurance, and private
placement variable universal life insurance. Individual annuities sales
consists of statutory premiums direct and assumed, excluding company
sponsored internal exchanges.
About MetLife
MetLife, Inc. is a leading global provider of insurance, annuities and
employee benefit programs, serving 90 million customers in over 50
countries. Through its subsidiaries and affiliates, MetLife holds
leading market positions in the United States, Japan, Latin America,
Asia Pacific, Europe and the Middle East. For more information, visit www.metlife.com.
This press release may contain or incorporate by reference information
that includes or is based upon forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements give expectations or forecasts of future
events. These statements can be identified by the fact that they do not
relate strictly to historical or current facts. They use words such as
"anticipate,” "estimate,” "expect,” "project,” "intend,” "plan,”
"believe” and other words and terms of similar meaning in connection
with a discussion of future operating or financial performance. In
particular, these include statements relating to future actions,
prospective services or products, future performance or results of
current and anticipated services or products, sales efforts, expenses,
the outcome of contingencies such as legal proceedings, trends in
operations and financial results.
Any or all forward-looking statements may turn out to be wrong. They can
be affected by inaccurate assumptions or by known or unknown risks and
uncertainties. Many such factors will be important in determining the
actual future results of MetLife, Inc., its subsidiaries and affiliates.
These statements are based on current expectations and the current
economic environment. They involve a number of risks and uncertainties
that are difficult to predict. These statements are not guarantees of
future performance. Actual results could differ materially from those
expressed or implied in the forward-looking statements. Risks,
uncertainties, and other factors that might cause such differences
include the risks, uncertainties and other factors identified in
MetLife, Inc.’s filings with the U.S. Securities and Exchange Commission
(the "SEC”). These factors include: (1) difficult conditions in the
global capital markets; (2) the delay by Congress in raising the
statutory debt limit of the U.S., as well as rating agency downgrades of
U.S. Treasury securities; (3) increased volatility and disruption of the
capital and credit markets, which may affect our ability to seek
financing or access our credit facilities; (4) uncertainty about the
effectiveness of the U.S. government’s programs to stabilize the
financial system, the imposition of fees relating thereto, or the
promulgation of additional regulations; (5) impact of comprehensive
financial services regulation reform on us; (6) exposure to financial
and capital market risk; (7) changes in general economic conditions,
including the performance of financial markets and interest rates, which
may affect our ability to raise capital, generate fee income and
market-related revenue and finance statutory reserve requirements and
may require us to pledge collateral or make payments related to declines
in value of specified assets; (8) potential liquidity and other risks
resulting from our participation in a securities lending program and
other transactions; (9) investment losses and defaults, and changes to
investment valuations; (10) impairments of goodwill and realized losses
or market value impairments to illiquid assets; (11) defaults on our
mortgage loans; (12) the impairment of other financial institutions that
could adversely affect our investments or business; (13) our ability to
address unforeseen liabilities, asset impairments, loss of key
contractual relationships, or rating actions arising from acquisitions
or dispositions, including our acquisition of American Life Insurance
Company and Delaware American Life Insurance Company (collectively,
"ALICO”) and to successfully integrate and manage the growth of acquired
businesses with minimal disruption; (14) uncertainty with respect to the
outcome of the closing agreement entered into with the United States
Internal Revenue Service in connection with the acquisition of ALICO;
(15) uncertainty with respect to any incremental tax benefits resulting
from the elections made for ALICO and certain of its subsidiaries under
Section 338 of the U.S. Internal Revenue Code of 1986, as amended; (16)
the dilutive impact on our stockholders resulting from the issuance of
equity securities in connection with the acquisition of ALICO or
otherwise; (17) economic, political, currency and other risks relating
to our international operations, including with respect to fluctuations
of exchange rates; (18) our primary reliance, as a holding company, on
dividends from our subsidiaries to meet debt payment obligations and the
applicable regulatory restrictions on the ability of the subsidiaries to
pay such dividends; (19) downgrades in our claims paying ability,
financial strength or credit ratings; (20) ineffectiveness of risk
management policies and procedures; (21) availability and effectiveness
of reinsurance or indemnification arrangements, as well as default or
failure of counterparties to perform; (22) discrepancies between actual
claims experience and assumptions used in setting prices for our
products and establishing the liabilities for our obligations for future
policy benefits and claims; (23) catastrophe losses; (24) heightened
competition, including with respect to pricing, entry of new
competitors, consolidation of distributors, the development of new
products by new and existing competitors, distribution of amounts
available under U.S. government programs, and for personnel; (25)
unanticipated changes in industry trends; (26) changes in accounting
standards, practices and/or policies; (27) changes in assumptions
related to deferred policy acquisition costs, deferred sales
inducements, value of business acquired or goodwill; (28) increased
expenses relating to pension and postretirement benefit plans, as well
as health care and other employee benefits; (29) exposure to losses
related to variable annuity guarantee benefits, including from
significant and sustained downturns or extreme volatility in equity
markets, reduced interest rates, unanticipated policyholder behavior,
mortality or longevity, and the adjustment for nonperformance risk; (30)
deterioration in the experience of the "closed block” established in
connection with the reorganization of Metropolitan Life Insurance
Company; (31) adverse results or other consequences from litigation,
arbitration or regulatory investigations; (32) inability to protect our
intellectual property rights or claims of infringement of the
intellectual property rights of others, (33) discrepancies between
actual experience and assumptions used in establishing liabilities
related to other contingencies or obligations; (34) regulatory,
legislative or tax changes relating to our insurance, banking,
international, or other operations that may affect the cost of, or
demand for, our products or services, impair our ability to attract and
retain talented and experienced management and other employees, or
increase the cost or administrative burdens of providing benefits to
employees; (35) the effects of business disruption or economic
contraction due to terrorism, other hostilities, or natural
catastrophes, including any related impact on our disaster recovery
systems and management continuity planning which could impair our
ability to conduct business effectively; (36) the effectiveness of our
programs and practices in avoiding giving our associates incentives to
take excessive risks; and (37) other risks and uncertainties described
from time to time in MetLife, Inc.’s filings with the SEC.
MetLife, Inc. does not undertake any obligation to publicly correct or
update any forward-looking statement if MetLife, Inc. later becomes
aware that such statement is not likely to be achieved. Please consult
any further disclosures MetLife, Inc. makes on related subjects in
reports to the SEC.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MetLife, Inc.
|
|
Interim Condensed Consolidated Statements of Operations
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months Ended
|
|
|
For the Nine Months Ended
|
|
|
|
|
September 30,
|
|
|
September 30,
|
|
|
|
|
2011
|
|
|
2010
|
|
|
2011
|
|
|
2010
|
|
|
|
|
(In millions)
|
|
Revenues
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums
|
|
|
$
|
9,342
|
|
|
|
$
|
6,484
|
|
|
|
$
|
27,190
|
|
|
|
$
|
19,856
|
|
|
Universal life and investment-type product policy fees
|
|
|
|
1,998
|
|
|
|
|
1,452
|
|
|
|
|
5,856
|
|
|
|
|
4,339
|
|
|
Net investment income
|
|
|
|
4,257
|
|
|
|
|
4,364
|
|
|
|
|
14,669
|
|
|
|
|
12,745
|
|
|
Other revenues
|
|
|
|
720
|
|
|
|
|
624
|
|
|
|
|
1,878
|
|
|
|
|
1,681
|
|
|
Net investment gains (losses):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other-than-temporary impairments on fixed maturity securities
|
|
|
|
(95
|
)
|
|
|
|
(143
|
)
|
|
|
|
(525
|
)
|
|
|
|
(538
|
)
|
|
Other-than-temporary impairments on fixed maturity securities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
transferred to other comprehensive income (loss)
|
|
|
|
(189
|
)
|
|
|
|
24
|
|
|
|
|
(5
|
)
|
|
|
|
181
|
|
|
Other net investment gains (losses)
|
|
|
|
229
|
|
|
|
|
(223
|
)
|
|
|
|
221
|
|
|
|
|
33
|
|
|
Total net investment gains (losses)
|
|
|
|
(55
|
)
|
|
|
|
(342
|
)
|
|
|
|
(309
|
)
|
|
|
|
(324
|
)
|
|
Net derivative gains (losses)
|
|
|
|
4,196
|
|
|
|
|
(244
|
)
|
|
|
|
4,233
|
|
|
|
|
1,278
|
|
|
Total revenues
|
|
|
|
20,458
|
|
|
|
|
12,338
|
|
|
|
|
53,517
|
|
|
|
|
39,575
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Policyholder benefits and claims
|
|
|
|
9,017
|
|
|
|
|
7,309
|
|
|
|
|
26,367
|
|
|
|
|
21,703
|
|
|
Interest credited to policyholder account balances
|
|
|
|
738
|
|
|
|
|
1,264
|
|
|
|
|
4,104
|
|
|
|
|
3,454
|
|
|
Policyholder dividends
|
|
|
|
384
|
|
|
|
|
391
|
|
|
|
|
1,130
|
|
|
|
|
1,156
|
|
|
Other expenses
|
|
|
|
5,013
|
|
|
|
|
2,989
|
|
|
|
|
13,410
|
|
|
|
|
9,330
|
|
|
Total expenses
|
|
|
|
15,152
|
|
|
|
|
11,953
|
|
|
|
|
45,011
|
|
|
|
|
35,643
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations before provision for income
tax
|
|
|
|
5,306
|
|
|
|
|
385
|
|
|
|
|
8,506
|
|
|
|
|
3,932
|
|
|
Provision for income tax expense (benefit)
|
|
|
|
1,734
|
|
|
|
|
68
|
|
|
|
|
2,681
|
|
|
|
|
1,251
|
|
|
Income (loss) from continuing operations, net of income tax
|
|
|
|
3,572
|
|
|
|
|
317
|
|
|
|
|
5,825
|
|
|
|
|
2,681
|
|
|
Income (loss) from discontinued operations, net of income tax
|
|
|
|
4
|
|
|
|
|
3
|
|
|
|
|
(6
|
)
|
|
|
|
20
|
|
|
Net income (loss)
|
|
|
|
3,576
|
|
|
|
|
320
|
|
|
|
|
5,819
|
|
|
|
|
2,701
|
|
|
Less: Net income (loss) attributable to noncontrolling interests
|
|
|
|
(6
|
)
|
|
|
|
4
|
|
|
|
|
(6
|
)
|
|
|
|
(7
|
)
|
|
Net income (loss) attributable to MetLife, Inc.
|
|
|
|
3,582
|
|
|
|
|
316
|
|
|
|
|
5,825
|
|
|
|
|
2,708
|
|
|
Less: Preferred stock dividends
|
|
|
|
30
|
|
|
|
|
30
|
|
|
|
|
91
|
|
|
|
|
91
|
|
|
Preferred stock redemption premium
|
|
|
|
-
|
|
|
|
|
-
|
|
|
|
|
146
|
|
|
|
|
-
|
|
|
Net income (loss) available to MetLife, Inc.'s common shareholders
|
|
|
$
|
3,552
|
|
|
|
$
|
286
|
|
|
|
$
|
5,588
|
|
|
|
$
|
2,617
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reconciliation to Operating Earnings Available to Common
Shareholders
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) available to MetLife, Inc.'s common shareholders
|
|
|
$
|
3,552
|
|
|
|
$
|
286
|
|
|
|
$
|
5,588
|
|
|
|
$
|
2,617
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjustments from net income (loss) available to MetLife, Inc.'s
common shareholders to operating earnings available to common
shareholders:
|
|
|
|
|
|
|
|
|
|
|
|
|
Less: Net investment gains (losses)
|
|
|
|
(55
|
)
|
|
|
|
(342
|
)
|
|
|
|
(309
|
)
|
|
|
|
(324
|
)
|
|
Less: Net derivative gains (losses)
|
|
|
|
4,196
|
|
|
|
|
(244
|
)
|
|
|
|
4,233
|
|
|
|
|
1,278
|
|
|
Less: Other adjustments to continuing operations
|
|
|
|
(478
|
)
|
|
|
|
(437
|
)
|
|
|
|
(1,064
|
)
|
|
|
|
(1,017
|
)
|
|
Less: Provision for income tax (expense) benefit
|
|
|
|
(1,300
|
)
|
|
|
|
352
|
|
|
|
|
(1,052
|
)
|
|
|
|
(83
|
)
|
|
Less: Income (loss) from discontinued operations, net of income tax
|
|
|
|
4
|
|
|
|
|
3
|
|
|
|
|
(6
|
)
|
|
|
|
20
|
|
|
Add: Net income (loss) attributable to noncontrolling interests
|
|
|
|
(6
|
)
|
|
|
|
4
|
|
|
|
|
(6
|
)
|
|
|
|
(7
|
)
|
|
Add: Preferred stock redemption premium
|
|
|
|
-
|
|
|
|
|
-
|
|
|
|
|
146
|
|
|
|
|
-
|
|
|
Operating earnings available to common shareholders
|
|
|
$
|
1,179
|
|
|
|
$
|
958
|
|
|
|
$
|
3,926
|
|
|
|
$
|
2,736
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reconciliation of GAAP revenues to operating revenues and GAAP
expenses to operating expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues
|
|
|
$
|
20,458
|
|
|
|
$
|
12,338
|
|
|
|
$
|
53,517
|
|
|
|
$
|
39,575
|
|
|
Less: Net investment gains (losses)
|
|
|
|
(55
|
)
|
|
|
|
(342
|
)
|
|
|
|
(309
|
)
|
|
|
|
(324
|
)
|
|
Less: Net derivative gains (losses)
|
|
|
|
4,196
|
|
|
|
|
(244
|
)
|
|
|
|
4,233
|
|
|
|
|
1,278
|
|
|
Less: Adjustments related to net investment gains (losses) and net
derivative gains (losses)
|
|
|
|
16
|
|
|
|
|
-
|
|
|
|
|
14
|
|
|
|
|
6
|
|
|
Less: Other adjustments to revenues
|
|
|
|
(716
|
)
|
|
|
|
104
|
|
|
|
|
(147
|
)
|
|
|
|
194
|
|
|
Total operating revenues
|
|
|
$
|
17,017
|
|
|
|
$
|
12,820
|
|
|
|
$
|
49,726
|
|
|
|
$
|
38,421
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total expenses
|
|
|
$
|
15,152
|
|
|
|
$
|
11,953
|
|
|
|
$
|
45,011
|
|
|
|
$
|
35,643
|
|
|
Less: Adjustments related to net investment gains (losses) and net
derivative gains (losses)
|
|
|
|
471
|
|
|
|
|
37
|
|
|
|
|
565
|
|
|
|
|
263
|
|
|
Less: Other adjustments to expenses
|
|
|
|
(693
|
)
|
|
|
|
504
|
|
|
|
|
366
|
|
|
|
|
954
|
|
|
Total operating expenses
|
|
|
$
|
15,374
|
|
|
|
$
|
11,412
|
|
|
|
$
|
44,080
|
|
|
|
$
|
34,426
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months Ended
|
|
|
For the Nine Months Ended
|
|
|
|
|
September 30,
|
|
|
September 30,
|
|
|
|
|
2011
|
|
|
2010
|
|
|
2011
|
|
|
2010
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted Earnings Per Common Share Calculation:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) available to MetLife, Inc.'s common shareholders
per common share - diluted
|
|
|
$
|
3.33
|
|
|
|
$
|
0.32
|
|
|
|
$
|
5.23
|
|
|
|
$
|
3.09
|
|
|
Less: Net investment gains (losses)
|
|
|
|
(0.05
|
)
|
|
|
|
(0.39
|
)
|
|
|
|
(0.29
|
)
|
|
|
|
(0.38
|
)
|
|
Less: Net derivative gains (losses)
|
|
|
|
3.94
|
|
|
|
|
(0.28
|
)
|
|
|
|
3.96
|
|
|
|
|
1.51
|
|
|
Less: Other adjustments to continuing operations
|
|
|
|
(0.46
|
)
|
|
|
|
(0.49
|
)
|
|
|
|
(0.99
|
)
|
|
|
|
(1.20
|
)
|
|
Less: Provision for income tax (expense) benefit
|
|
|
|
(1.22
|
)
|
|
|
|
0.40
|
|
|
|
|
(0.98
|
)
|
|
|
|
(0.10
|
)
|
|
Less: Income (loss) from discontinued operations, net of income tax
|
|
|
|
-
|
|
|
|
|
-
|
|
|
|
|
(0.01
|
)
|
|
|
|
0.02
|
|
|
Add: Net income (loss) attributable to noncontrolling interest
|
|
|
|
(0.01
|
)
|
|
|
|
-
|
|
|
|
|
(0.01
|
)
|
|
|
|
(0.01
|
)
|
|
Add: Preferred stock redemption premium
|
|
|
|
-
|
|
|
|
|
-
|
|
|
|
|
0.14
|
|
|
|
|
-
|
|
|
Operating earnings available to common shareholders per common share
- diluted
|
|
|
$
|
1.11
|
|
|
|
$
|
1.08
|
|
|
|
$
|
3.67
|
|
|
|
$
|
3.23
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average common shares outstanding - diluted
|
|
|
|
1,066.2
|
|
|
|
|
883.1
|
|
|
|
|
1,068.7
|
|
|
|
|
847.3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
September 30,
|
|
|
|
|
|
|
|
|
|
|
2011
|
|
|
2010
|
|
Book Value Per Common Share Calculation :
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Book value per common share - (actual common shares outstanding)
|
|
|
|
|
|
|
|
|
$
|
55.13
|
|
|
|
$
|
48.93
|
|
|
Less: Accumulated other comprehensive income (loss) per common share
|
|
|
|
|
|
|
|
|
|
6.44
|
|
|
|
|
4.45
|
|
|
Book value per common share, excluding accumulated other
comprehensive income (loss) - (actual common shares outstanding)
|
|
|
|
|
|
|
|
|
$
|
48.69
|
|
|
|
$
|
44.48
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common shares outstanding, end of period
|
|
|
|
|
|
|
|
|
|
1,057.6
|
|
|
|
|
906.9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MetLife, Inc.
|
|
Reconciliations of Net Income (Loss) Available to Common
Shareholders to Operating Earnings Available to Common Shareholders
|
|
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months Ended
|
|
|
For the Nine Months Ended
|
|
|
|
|
September 30,
|
|
|
September 30,
|
|
|
|
|
2011
|
|
|
2010
|
|
|
2011
|
|
|
2010
|
|
|
|
|
(In millions)
|
|
|
(In millions)
|
|
Total U.S. Business Operations:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) available to MetLife, Inc.'s common shareholders
|
|
|
$
|
2,527
|
|
|
|
$
|
764
|
|
|
|
$
|
4,415
|
|
|
|
$
|
3,084
|
|
|
Less: Net investment gains (losses)
|
|
|
|
118
|
|
|
|
|
125
|
|
|
|
|
203
|
|
|
|
|
282
|
|
|
Less: Net derivative gains (losses)
|
|
|
|
2,953
|
|
|
|
|
5
|
|
|
|
|
3,127
|
|
|
|
|
1,208
|
|
|
Less: Other adjustments to continuing operations
|
|
|
|
(207
|
)
|
|
|
|
(263
|
)
|
|
|
|
(429
|
)
|
|
|
|
(522
|
)
|
|
Less: Provision for income tax (expense) benefit
|
|
|
|
(1,002
|
)
|
|
|
|
47
|
|
|
|
|
(1,016
|
)
|
|
|
|
(347
|
)
|
|
Less: Income (loss) from discontinued operations, net of income tax
|
|
|
|
13
|
|
|
|
|
4
|
|
|
|
|
62
|
|
|
|
|
14
|
|
|
Add: Net income (loss) attributable to noncontrolling interest
|
|
|
|
3
|
|
|
|
|
-
|
|
|
|
|
3
|
|
|
|
|
1
|
|
|
Operating earnings available to common shareholders
|
|
|
$
|
655
|
|
|
|
$
|
846
|
|
|
|
$
|
2,471
|
|
|
|
$
|
2,450
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Insurance Products:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) available to MetLife, Inc.'s common shareholders
|
|
|
$
|
1,258
|
|
|
|
$
|
401
|
|
|
|
$
|
2,098
|
|
|
|
$
|
1,405
|
|
|
Less: Net investment gains (losses)
|
|
|
|
15
|
|
|
|
|
69
|
|
|
|
|
55
|
|
|
|
|
78
|
|
|
Less: Net derivative gains (losses)
|
|
|
|
1,597
|
|
|
|
|
86
|
|
|
|
|
1,689
|
|
|
|
|
711
|
|
|
Less: Other adjustments to continuing operations
|
|
|
|
(97
|
)
|
|
|
|
(70
|
)
|
|
|
|
(208
|
)
|
|
|
|
(187
|
)
|
|
Less: Provision for income tax (expense) benefit
|
|
|
|
(530
|
)
|
|
|
|
(29
|
)
|
|
|
|
(538
|
)
|
|
|
|
(211
|
)
|
|
Less: Income (loss) from discontinued operations, net of income tax
|
|
|
|
8
|
|
|
|
|
-
|
|
|
|
|
36
|
|
|
|
|
2
|
|
|
Operating earnings available to common shareholders
|
|
|
$
|
265
|
|
|
|
$
|
345
|
|
|
|
$
|
1,064
|
|
|
|
$
|
1,012
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Retirement Products:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) available to MetLife, Inc.'s common shareholders
|
|
|
$
|
667
|
|
|
|
$
|
185
|
|
|
|
$
|
1,173
|
|
|
|
$
|
782
|
|
|
Less: Net investment gains (losses)
|
|
|
|
21
|
|
|
|
|
5
|
|
|
|
|
72
|
|
|
|
|
96
|
|
|
Less: Net derivative gains (losses)
|
|
|
|
956
|
|
|
|
|
116
|
|
|
|
|
1,220
|
|
|
|
|
627
|
|
|
Less: Other adjustments to continuing operations
|
|
|
|
(110
|
)
|
|
|
|
(203
|
)
|
|
|
|
(281
|
)
|
|
|
|
(404
|
)
|
|
Less: Provision for income tax (expense) benefit
|
|
|
|
(303
|
)
|
|
|
|
28
|
|
|
|
|
(354
|
)
|
|
|
|
(113
|
)
|
|
Less: Income (loss) from discontinued operations, net of income tax
|
|
|
|
-
|
|
|
|
|
1
|
|
|
|
|
-
|
|
|
|
|
1
|
|
|
Add: Net income (loss) attributable to noncontrolling interest
|
|
|
|
1
|
|
|
|
|
-
|
|
|
|
|
1
|
|
|
|
|
-
|
|
|
Operating earnings available to common shareholders
|
|
|
$
|
104
|
|
|
|
$
|
238
|
|
|
|
$
|
517
|
|
|
|
$
|
575
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate Benefit Funding:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) available to MetLife, Inc.'s common shareholders
|
|
|
$
|
587
|
|
|
|
$
|
102
|
|
|
|
$
|
1,134
|
|
|
|
$
|
678
|
|
|
Less: Net investment gains (losses)
|
|
|
|
86
|
|
|
|
|
54
|
|
|
|
|
86
|
|
|
|
|
111
|
|
|
Less: Net derivative gains (losses)
|
|
|
|
407
|
|
|
|
|
(193
|
)
|
|
|
|
228
|
|
|
|
|
(123
|
)
|
|
Less: Other adjustments to continuing operations
|
|
|
|
-
|
|
|
|
|
10
|
|
|
|
|
60
|
|
|
|
|
69
|
|
|
Less: Provision for income tax (expense) benefit
|
|
|
|
(173
|
)
|
|
|
|
46
|
|
|
|
|
(131
|
)
|
|
|
|
(26
|
)
|
|
Less: Income (loss) from discontinued operations, net of income tax
|
|
|
|
5
|
|
|
|
|
3
|
|
|
|
|
26
|
|
|
|
|
11
|
|
|
Add: Net income (loss) attributable to noncontrolling interest
|
|
|
|
2
|
|
|
|
|
-
|
|
|
|
|
2
|
|
|
|
|
1
|
|
|
Operating earnings available to common shareholders
|
|
|
$
|
264
|
|
|
|
$
|
182
|
|
|
|
$
|
867
|
|
|
|
$
|
637
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Auto & Home:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) available to MetLife, Inc.'s common shareholders
|
|
|
$
|
15
|
|
|
|
$
|
76
|
|
|
|
$
|
10
|
|
|
|
$
|
219
|
|
|
Less: Net investment gains (losses)
|
|
|
|
(4
|
)
|
|
|
|
(3
|
)
|
|
|
|
(10
|
)
|
|
|
|
(3
|
)
|
|
Less: Net derivative gains (losses)
|
|
|
|
(7
|
)
|
|
|
|
(4
|
)
|
|
|
|
(10
|
)
|
|
|
|
(7
|
)
|
|
Less: Provision for income tax (expense) benefit
|
|
|
|
4
|
|
|
|
|
2
|
|
|
|
|
7
|
|
|
|
|
3
|
|
|
Operating earnings available to common shareholders
|
|
|
$
|
22
|
|
|
|
$
|
81
|
|
|
|
$
|
23
|
|
|
|
$
|
226
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total International Operations:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) available to MetLife, Inc.'s common shareholders
|
|
|
$
|
1,070
|
|
|
|
$
|
(137
|
)
|
|
|
$
|
1,719
|
|
|
|
$
|
56
|
|
|
Less: Net investment gains (losses)
|
|
|
|
(261
|
)
|
|
|
|
(239
|
)
|
|
|
|
(500
|
)
|
|
|
|
(268
|
)
|
|
Less: Net derivative gains (losses)
|
|
|
|
1,273
|
|
|
|
|
(109
|
)
|
|
|
|
1,215
|
|
|
|
|
157
|
|
|
Less: Other adjustments to continuing operations
|
|
|
|
(199
|
)
|
|
|
|
(145
|
)
|
|
|
|
(413
|
)
|
|
|
|
(413
|
)
|
|
Less: Provision for income tax (expense) benefit
|
|
|
|
(320
|
)
|
|
|
|
169
|
|
|
|
|
(169
|
)
|
|
|
|
87
|
|
|
Less: Income (loss) from discontinued operations, net of income tax
|
|
|
|
(11
|
)
|
|
|
|
2
|
|
|
|
|
(71
|
)
|
|
|
|
9
|
|
|
Add: Net income (loss) attributable to noncontrolling interest
|
|
|
|
(10
|
)
|
|
|
|
4
|
|
|
|
|
(5
|
)
|
|
|
|
(6
|
)
|
|
Operating earnings available to common shareholders
|
|
|
$
|
578
|
|
|
|
$
|
189
|
|
|
|
$
|
1,652
|
|
|
|
$
|
478
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Japan:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) available to MetLife, Inc.'s common shareholders
|
|
|
$
|
339
|
|
|
|
$
|
-
|
|
|
|
$
|
931
|
|
|
|
$
|
-
|
|
|
Less: Net investment gains (losses)
|
|
|
|
(21
|
)
|
|
|
|
-
|
|
|
|
|
(115
|
)
|
|
|
|
-
|
|
|
Less: Net derivative gains (losses)
|
|
|
|
101
|
|
|
|
|
-
|
|
|
|
|
228
|
|
|
|
|
-
|
|
|
Less: Other adjustments to continuing operations
|
|
|
|
(42
|
)
|
|
|
|
-
|
|
|
|
|
15
|
|
|
|
|
-
|
|
|
Less: Provision for income tax (expense) benefit
|
|
|
|
(12
|
)
|
|
|
|
-
|
|
|
|
|
(44
|
)
|
|
|
|
-
|
|
|
Add: Net income (loss) attributable to noncontrolling interest
|
|
|
|
2
|
|
|
|
|
-
|
|
|
|
|
3
|
|
|
|
|
-
|
|
|
Operating earnings available to common shareholders
|
|
|
$
|
315
|
|
|
|
$
|
-
|
|
|
|
$
|
850
|
|
|
|
$
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other International Regions:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) available to MetLife, Inc.'s common shareholders
|
|
|
$
|
731
|
|
|
|
$
|
(137
|
)
|
|
|
$
|
788
|
|
|
|
$
|
56
|
|
|
Less: Net investment gains (losses)
|
|
|
|
(240
|
)
|
|
|
|
(239
|
)
|
|
|
|
(385
|
)
|
|
|
|
(268
|
)
|
|
Less: Net derivative gains (losses)
|
|
|
|
1,172
|
|
|
|
|
(109
|
)
|
|
|
|
987
|
|
|
|
|
157
|
|
|
Less: Other adjustments to continuing operations
|
|
|
|
(157
|
)
|
|
|
|
(145
|
)
|
|
|
|
(428
|
)
|
|
|
|
(413
|
)
|
|
Less: Provision for income tax (expense) benefit
|
|
|
|
(308
|
)
|
|
|
|
169
|
|
|
|
|
(125
|
)
|
|
|
|
87
|
|
|
Less: Income (loss) from discontinued operations, net of income tax
|
|
|
|
(11
|
)
|
|
|
|
2
|
|
|
|
|
(71
|
)
|
|
|
|
9
|
|
|
Add: Net income (loss) attributable to noncontrolling interest
|
|
|
|
(12
|
)
|
|
|
|
4
|
|
|
|
|
(8
|
)
|
|
|
|
(6
|
)
|
|
Operating earnings available to common shareholders
|
|
|
$
|
263
|
|
|
|
$
|
189
|
|
|
|
$
|
802
|
|
|
|
$
|
478
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Banking, Corporate & Other:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) available to MetLife, Inc.'s common shareholders
|
|
|
$
|
(45
|
)
|
|
|
$
|
(341
|
)
|
|
|
$
|
(546
|
)
|
|
|
$
|
(523
|
)
|
|
Less: Net investment gains (losses)
|
|
|
|
88
|
|
|
|
|
(228
|
)
|
|
|
|
(12
|
)
|
|
|
|
(338
|
)
|
|
Less: Net derivative gains (losses)
|
|
|
|
(30
|
)
|
|
|
|
(140
|
)
|
|
|
|
(109
|
)
|
|
|
|
(87
|
)
|
|
Less: Other adjustments to continuing operations
|
|
|
|
(72
|
)
|
|
|
|
(29
|
)
|
|
|
|
(222
|
)
|
|
|
|
(82
|
)
|
|
Less: Provision for income tax (expense) benefit
|
|
|
|
22
|
|
|
|
|
136
|
|
|
|
|
133
|
|
|
|
|
177
|
|
|
Less: Income (loss) from discontinued operations, net of income tax
|
|
|
|
2
|
|
|
|
|
(3
|
)
|
|
|
|
3
|
|
|
|
|
(3
|
)
|
|
Add: Net income (loss) attributable to noncontrolling interest
|
|
|
|
1
|
|
|
|
|
-
|
|
|
|
|
(4
|
)
|
|
|
|
(2
|
)
|
|
Add: Preferred stock redemption premium
|
|
|
|
-
|
|
|
|
|
-
|
|
|
|
|
146
|
|
|
|
|
-
|
|
|
Operating earnings available to common shareholders
|
|
|
$
|
(54
|
)
|
|
|
$
|
(77
|
)
|
|
|
$
|
(197
|
)
|
|
|
$
|
(192
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
